InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.44
(
-0.50%
)
US TECH 100
18,416.80
(
-0.75%
)
Dow Jones
40,743.33
(
0.50%
)
Brent Oil
79.30
(
0.93%
)
Bitcoin
65,660.09
(
-0.77%
)
Post# of 252748
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Bio_pete

Send PM Follow Ignore
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Bio_pete

Re: mcbio post# 137513

Tuesday, 02/21/2012 6:15:17 PM

Tuesday, February 21, 2012 6:15:17 PM

Post# of 252748
"I don't want to rain on the THLD parade as this is certainly positive news for them. However, we don't know anything about OS yet. If there turns out to be no OS benefit for the TH-302 arm, I would imagine THLD shares could suffer the same fate as those of ECYT, which have been crushed since the promising PFS data in ovarian cancer patients didn't turn into an OS benefit."

Then why do it? Everyone is always looking for the worse case scenario & thats why most here just missed out on a nice gain. What if results are better then their competitors?
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up